"It's a good sign that development in Germany has reached the point
where we can begin initial clinical trials," Spahn told reporters.
"At the same time it's important to stress that it will take months
for any vaccine to be fully tested and available even if we have now
started the first clinical studies," he said.
(Reporting by Michelle Martin, editing by Thomas Escritt)
[© 2020 Thomson Reuters. All rights
reserved.] Copyright 2020 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content. |